Repligen (RGEN) Revenue (2010 - 2026)

Repligen (RGEN) has 17 years of Revenue data on file, last reported at $194.3 million in Q1 2026.

• Revenue for Q1 2026 came in at $194.3 million, up 14.83% year-over-year; the trailing twelve-month figure through Mar 2026 was $763.3 million (up 17.36% YoY), and the FY2025 annual result was $738.3 million, up 16.36% from the prior year.
• Revenue declined to $194.3 million in Q1 2026 per RGEN's latest filing, from $197.9 million in the prior quarter.
• Over five years, Revenue peaked at $207.6 million in Q2 2022 and troughed at $17.3 million in Q1 2023.
• A 5-year average of $167.8 million and a median of $169.2 million in 2025 frame the typical range for Revenue.
• The sharpest annual moves came in 2023 and 2024: Revenue sank 91.62% in 2023, then jumped 785.45% in 2024.
• A 5-year view of Revenue shows it stood at $186.8 million in 2022, then declined by 10.78% to $166.6 million in 2023, then increased by 0.56% to $167.5 million in 2024, then gained by 18.12% to $197.9 million in 2025, then slipped by 1.85% to $194.3 million in 2026.
• Business Quant data shows RGEN's Revenue at $194.3 million in Q1 2026, $197.9 million in Q4 2025, and $188.8 million in Q3 2025.